This HTML5 document contains 191 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n8http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n3http://linked.opendata.cz/ontology/sukl/
n10http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149621/price-of-originator/
n19http://linked.opendata.cz/resource/sukl/specialization-restriction/
n20http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149621/reimbursement/
skoshttp://www.w3.org/2004/02/skos/core#
n14http://linked.opendata.cz/resource/sukl/indgroup/
n7http://linked.opendata.cz/resource/sukl/packing/
n15http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149621/core-reimbursement/
n4http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149621/
n11http://linked.opendata.cz/resource/sukl/company/
n13http://www.emea.europa.eu/docs/cs_CZ/document_library/EPAR_-_Product_Information/human/001033/
n5http://linked.opendata.cz/resource/sukl/active-ingredient/
n16http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0149621/price/
n6http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n18http://linked.opendata.cz/resource/sukl/registration-state/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/atc/
n9http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item
n2:0149621
rdf:type
n3:MedicinalProductPackaging
dcterms:title
EPORATIO 3000 IU/0,5 ML
skos:notation
0149621
n3:hasATCCode
n12:B03XA01
n3:hasActiveIngredient
n5:EPOETINUM-THETA
n3:hasDefinedDailyDose
n4:ddd
n3:hasDosageForm
n9:INJ-SOL-SDR-IVN
n3:hasPackagingSize
6X0.5ML I
n3:hasPacking
n7:ISP
n3:hasRegistrationHolder
n11:RATD
n3:hasRegistrationState
n18:R
n3:hasRouteOfAdministration
n8:SDR-IVN
n3:hasStrength
6000IU/ML
n3:hasIndicationGroup
n14:12
n3:hasSpecializationRestriction
n6:blank-cell n19:INT n19:HEM n19:NEF n19:ONK n19:PED
n3:containsDefinedDailyDoses
18.0
n3:hasRegistrationCode
EU/1/09/573/005
n3:hasTitleSupplement
SDR+IVN INJ SOL 6X0.5ML I
n3:containsUsualTherapeuticalDailyDoses
18
n3:hasBreakMarketingDate
2011-08-16+02:00 2014-02-24+01:00
n3:hasCoreReimbursementSpecification
n15:2013-12-01 n15:2014-01-01 n15:2013-10-01 n15:2013-11-01 n15:2013-08-03 n15:2013-09-01 n15:2013-07-01 n15:2013-08-01 n15:2014-07-01 n15:2014-07-03 n15:2014-06-01 n15:2014-06-13 n15:2014-04-01 n15:2014-05-01 n15:2014-02-01 n15:2014-03-01 n15:2013-05-01 n15:2013-06-01 n15:2013-03-01 n15:2013-04-01 n15:2013-01-05 n15:2013-02-01 n15:2013-01-01 n15:2015-07-02 n15:2014-12-01 n15:2015-01-01 n15:2014-11-01 n15:2014-11-19 n15:2014-10-01 n15:2014-10-02 n15:2014-08-01 n15:2014-09-01 n15:2015-06-01 n15:2015-07-01 n15:2015-04-02 n15:2015-05-01 n15:2015-03-01 n15:2015-04-01 n15:2015-01-13 n15:2015-02-01
n3:hasIndicationRestriction
P
n3:hasPriceOfOriginatorSpecification
n10:2013-08-03 n10:2013-09-01 n10:2013-07-01 n10:2013-08-01 n10:2013-12-01 n10:2014-01-01 n10:2013-10-01 n10:2013-11-01 n10:2013-01-05 n10:2013-02-01 n10:2013-01-01 n10:2013-05-01 n10:2013-06-01 n10:2013-03-01 n10:2013-04-01 n10:2014-10-01 n10:2014-10-02 n10:2014-08-01 n10:2014-09-01 n10:2014-12-01 n10:2015-01-01 n10:2014-11-01 n10:2014-11-19 n10:2014-04-01 n10:2014-05-01 n10:2014-02-01 n10:2014-03-01 n10:2014-07-01 n10:2014-07-03 n10:2014-06-01 n10:2014-06-13 n10:2015-07-02 n10:2015-03-01 n10:2015-04-01 n10:2015-01-13 n10:2015-02-01 n10:2015-06-01 n10:2015-07-01 n10:2015-04-02 n10:2015-05-01
n3:hasPriceSpecification
n16:2014-06-01 n16:2014-06-13 n16:2014-07-01 n16:2014-07-03 n16:2014-02-01 n16:2014-03-01 n16:2014-04-01 n16:2014-05-01 n16:2013-10-01 n16:2013-11-01 n16:2013-12-01 n16:2014-01-01 n16:2013-07-01 n16:2013-08-01 n16:2013-08-03 n16:2013-09-01 n16:2015-04-02 n16:2015-05-01 n16:2015-06-01 n16:2015-07-01 n16:2015-01-13 n16:2015-02-01 n16:2015-03-01 n16:2015-04-01 n16:2014-11-01 n16:2014-11-19 n16:2014-12-01 n16:2015-01-01 n16:2014-08-01 n16:2014-09-01 n16:2014-10-01 n16:2014-10-02 n16:2013-03-01 n16:2013-04-01 n16:2013-05-01 n16:2013-06-01 n16:2013-01-01 n16:2013-01-05 n16:2013-02-01 n16:2015-07-02
n3:hasReimbursementSpecification
n20:2015-07-02 n20:2015-06-01 n20:2015-07-01 n20:2015-04-02 n20:2015-05-01 n20:2015-03-01 n20:2015-04-01 n20:2015-01-13 n20:2015-02-01 n20:2013-12-01 n20:2014-01-01 n20:2013-10-01 n20:2013-11-01 n20:2013-08-03 n20:2013-09-01 n20:2013-07-01 n20:2013-08-01 n20:2013-05-01 n20:2013-06-01 n20:2013-03-01 n20:2013-04-01 n20:2013-01-05 n20:2013-02-01 n20:2013-01-01 n20:2014-12-01 n20:2015-01-01 n20:2014-11-01 n20:2014-11-19 n20:2014-10-01 n20:2014-10-02 n20:2014-08-01 n20:2014-09-01 n20:2014-07-01 n20:2014-07-03 n20:2014-06-01 n20:2014-06-13 n20:2014-04-01 n20:2014-05-01 n20:2014-02-01 n20:2014-03-01
n3:hasResumedMarketingDate
2011-11-16+01:00
n3:hasUsualTherapeuticalDailyDose
n4:utdd
n3:spcFile
http%3A%2F%2Fwww.emea.europa.eu%2Fdocs%2Fcs_CZ%2Fdocument_library%2FEPAR_-_Product_Information%2Fhuman%2F001033%2FWC500043300.pdf
n3:spcUri
n13:WC500043300.pdf